Routine fetal cardiac screening: what are we doing and what should we do?

被引:59
|
作者
Sharland, G [1 ]
机构
[1] Guys Hosp, Fetal Cardiol Unit, London SE1 9RT, England
关键词
heart defects prenatal; ultrasonography prenatal; screening prenatal;
D O I
10.1002/pd.1069
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In many countries, ultrasound examination is used in the second trimester to look for congenital malformations as part of routine prenatal care. While tertiary centres scanning high-risk pregnancies have reported a high degree of accuracy in the detection of congenital heart disease, many studies have shown that cardiac abnormalities are commonly overlooked during routine obstetric evaluation and there still remains a huge variation between centres. The majority of babies with congenital heart disease are born to mothers with no identifiable high-risk factors and so will not be detected unless there is widespread screening of the low-risk population. It is feasible to achieve widespread screening for fetal congenital heart disease in low-risk groups, but this does need commitment and effort from those performing the scans and those teaching them how to examine the heart. Staff performing routine obstetric ultrasound scans should learn a simple technique for examining the fetal heart and to use this in all patients. Links to a tertiary centre can provide support for checking scans of concern as well as for providing training and for obtaining feedback. In addition, an audit system needs to be established in each centre to trace false-positive and false-negative cases as well as to confirm true positives and true negatives. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:1123 / 1129
页数:7
相关论文
共 50 条
  • [31] What Do We Think We're Doing?
    Meinwald, Constance
    PLATO JOURNAL, 2016, 16 : 9 - 20
  • [32] Noninvasive ventilation: Are we doing what we know we should?
    Una Orejon, R.
    Ureta Tolsada, P.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2010, 57 (10): : 611 - 612
  • [33] Neurocognitive enhancement: what can we do and what should we do?
    Farah, MJ
    Illes, J
    Cook-Deegan, R
    Gardner, H
    Kandel, E
    King, P
    Parens, E
    Sahakian, B
    Wolpe, PR
    NATURE REVIEWS NEUROSCIENCE, 2004, 5 (05) : 421 - 425
  • [34] ON WITH DOING WHAT WE DO BEST
    JUENEMAN, FB
    CHEMICAL & ENGINEERING NEWS, 1983, 61 (24) : 88 - 89
  • [35] Organizing the dissemination and implementation field: who are we, what are we doing, and how should we do it?
    Gretchen J. R. Buchanan
    Lindsey M. Filiatreau
    Julia E. Moore
    Implementation Science Communications, 5 (1):
  • [36] Bifurcation Disease What Do We Know, What Should We Do?
    Latib, Azeem
    Colombo, Antonio
    JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (03) : 218 - 226
  • [37] Cannabis and psychosis: what do we know and what should we do?
    Colizzi, Marco
    Murray, Robin
    BRITISH JOURNAL OF PSYCHIATRY, 2018, 212 (04) : 195 - 196
  • [38] What we were doing and what do we do? The verb do in the history of Spanish
    Porto Dapena, Jose Alvaro
    REVISTA DE FILOLOGIA ESPANOLA, 2010, 90 (01): : 203 - 207
  • [39] Neighborhoods and Health: What Do We Know? What Should We Do?
    Roux, Ana V. Diez
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (03) : 430 - 431
  • [40] Neurocognitive enhancement: what can we do and what should we do?
    Martha J. Farah
    Judy Illes
    Robert Cook-Deegan
    Howard Gardner
    Eric Kandel
    Patricia King
    Eric Parens
    Barbara Sahakian
    Paul Root Wolpe
    Nature Reviews Neuroscience, 2004, 5 : 421 - 425